Research prototype, not medical advice.

In a randomized trial, one donor-feces infusion cured 81% of recurrent C. difficile infections versus 31% with vancomycin alone; FMT is approved for this infection, not for aging.

Confidence
Established
Level of evidence
Approved by a health authority
Observed in
Human
Mission
Map of aging (12 hallmarks)
Concepts
DysbiosisFecal microbiota transplantation (FMT)Recurrent Clostridioides difficile infection

What the sources say

Each row is an article. “Supports”: it backs the claim. “Contradicts”: it goes against it. “Qualifies”: it limits it (another species, a weaker effect…).

DirectionSourceWhere in the articleStatus
Supports Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood et al. · New England Journal of Medicine 2013
— Verified